Feedback
LUPIN 
Reputation: 642,681 • Sep 25, 2023 3:51 PM
Outlook on healthcare sector; Cipla & Sun Pharma could give 15-20% return
ANDA approval rate has been on a steady rise post-COVID, from the low of 540 in CY21 to ~700+ annual approvals in CY23E, backed by a reduction in approval timeline and clearance of the backlog.
The Economic Times
1 Vote
Comment
3 Shares
NSE:LUPIN price when posted: 1,098.6
View Votes